Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans

Journal of the American Veterinary Medical Association

Volumn 225, Issue 3, 2004, Pages 368-373

  Sannes, Mark R ^a,b   Kuskowski, Michael A ^a,c   Johnson, James R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; SULFAFURAZOLE; TIMENTIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTITIS; DIFFUSION; DOG DISEASE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; PYELONEPHRITIS; REVIEW; SEROPREVALENCE; SPECIES DIFFERENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; CROSS-SECTIONAL STUDIES; CYSTITIS; DISEASE RESERVOIRS; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; PUBLIC HEALTH; PYELONEPHRITIS; REPRODUCIBILITY OF RESULTS; URINE; ZOONOSES;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 3342925968     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.225.368     Document Type: Review

References (21)

1. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745-758.
2. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:41-50.
3. Kahlmeter G. The ECO SENS project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J Antimicrob Chemother 2000;46(suppl 1):15-22.
4. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991;4:80-128.
5. Johnson JR, Stell AL, Delavari P. Canine feces as a reservoir of extraintestinal pathogenic Escherichia coli. Infect Immun 2001;59: 1306-1314.
6. Johnson JR, Kaster N, Kuskowski MA, et al. Identification of urovirulence traits in Escherichia coli by comparison of urinary and rectal E coli isolates from dogs with urinary tract infection. J Clin Microbiol 2003;41:337-345.
7. Johnson JR, Stell AL, Delavari P, et al. Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans. J Infect Dis 2001;183:897-906.
8. Johnson JR, O'Bryan TT, Low DA, et al. Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III. Infect Immun 2000;68:3327-3336.
9. Johnson JR, Delavari P, Stell AL, et al. Molecular comparison of extraintestinal Escherichia coli isolates of the same electropheretic lineages from humans and domestic animals. J Infect Dis 2001;183:154-159.
10. Cooke CL, Singer RS, Jang SS, et al. Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. J Am Vet Med Assoc 2002;220:190-192.
11. Manges AR, Johnson JR, Foxman B, et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001;345:1007-1013.
12. Johnson JR, Manges AR, O'Bryan TT, et al. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 2002;359:2249-2251.
13. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000;283:1583-1590.
14. Johnson JR, Brown JJ, Carlino UB, et al. Colonization with and acquisition of uropathogenic Escherichia coli as revealed by polymerase chain reaction-based detection. J Infect Dis 1998;177:1120-1124.
15. Lidin-Janson G, Kaijser B, Lincoln K, et al. The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Med Microbiol Immunol (Berl) 1978;164:247-253.
16. NCCLS. Performance standards for antimicrobial disk susceptibility tests: approved standard. 7th ed. Document M2-A7. Wayne, Pa: NCCLS, 2000;20:1-18.
17. NCCLS. Supplemental tables: disk diffusion. Document M100-S10 (M2). Wayne, Pa: NCCLS, 2000;14-18.
18. Boyle VJ, Fancher ME, Ross RW Jr. Rapid, modified Kirby-Bauer susceptibility test with single, high-concentration antimicrobial disks. Antimicrob Agents Chemother 1973;3:418-424.
19. Johnson JR, Moseley SL, Roberts PL, et al. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988;56:405-412.
20. Vila J, Simon K, Ruiz J, et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 2002;186: 1039-1042.
21. Gupta K, Sahm DF, Mayfield D, et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001;33:89-94.